CCMU
INO icon

Cheyne Capital Management (UK)’s Inovio Pharmaceuticals INO Stock Holding History

Cheyne Capital Management (UK)’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-5,833
Closed -$404K – 38
2015
Q3 		$404K Sell
5,833
-7,500
-56% -$653K 0.19% 33
2015
Q2 		$1.3M Buy
13,333
+9,166
+220% +$979K 0.42% 38
2015
Q1 		$408K Buy
+4,167
New +$404K 0.1% 58

Other funds holding INO

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
SIP
Stoneridge Investment Partners Radnor, Pennsylvania $138M AUM 7.66% 1-Year Est. Return

Cheyne Capital Management (UK)'s INO Position: Q4 2015 in Review

Cheyne Capital Management (UK) sold out of Inovio Pharmaceuticals (INO) in Q4 2015, closing a stake of 5,833 shares — an estimated $404K sold.

Cheyne Capital Management (UK) first reported a position in INO in Q1 2015 and held it in 3 quarters. The position peaked at $1.3M in Q2 2015. 123 funds tracked by Wall St. Rank hold INO as of Q4 2015.

  • Cheyne Capital Management (UK) reported no remaining Inovio Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • Cheyne Capital Management (UK) sold 5,833 Inovio Pharmaceuticals shares in Q4 2015, an estimated $404K.
  • Cheyne Capital Management (UK) first reported a position in Inovio Pharmaceuticals in Q1 2015 and held it in 3 quarters.
  • Cheyne Capital Management (UK)'s Inovio Pharmaceuticals position peaked at $1.3M in Q2 2015.
  • 123 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q4 2015.

Based on Cheyne Capital Management (UK)'s 13F filing for Q4 2015, filed 15 Jan 2016.